Sandoz Group AG Cash Flow Conversion Efficiency

Latest as of June 2026: 0.094x

Sandoz Group AG cash flow conversion efficiency. Based on the latest financial reports, Sandoz Group AG (SDZ) has a cash flow conversion efficiency ratio of 0.094x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF851.94 Million ≈ $1.08 Billion USD) by net assets (CHF9.03 Billion ≈ $11.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sandoz Group AG (2020–2025)

Cash flow conversion efficiency of Sandoz Group AG from 2020 to 2025. This chart illustrates how Sandoz Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sandoz Group AG stock quote for real-time trading data and today's change.

Sandoz Group AG Cash Flow Conversion Ratio Explained

Sandoz Group AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sandoz Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sandoz Group AG ranked by their cash flow conversion efficiency. Also see Sandoz Group AG (SDZ) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Mettler-Toledo International Inc
NYSE:MTD
24.208x
Atmos Energy Corporation
NYSE:ATO
0.025x
Teledyne Technologies Incorporated
NYSE:TDY
0.022x
Hannover Rück SE
F:HNR1
0.128x
KONE Oyj
HE:KNEBV
0.129x
DexCom Inc
NASDAQ:DXCM
0.178x
Jabil Circuit Inc
NYSE:JBL
0.403x
Heidelberg Materials AG
XETRA:HEI
0.169x

Annual Cash Flow Conversion Efficiency for Sandoz Group AG (2020–2025)

The table below shows the annual cash flow conversion efficiency of Sandoz Group AG from 2020 to 2025. Review Sandoz Group AG free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF9.38 Billion
≈ $11.87 Billion
CHF1.59 Billion
≈ $2.02 Billion
0.170x +111.37%
2024-12-31 CHF8.16 Billion
≈ $10.32 Billion
CHF656.00 Million
≈ $829.36 Million
0.080x +113.76%
2023-12-31 CHF8.65 Billion
≈ $10.94 Billion
CHF325.31 Million
≈ $411.28 Million
0.038x -100.00%
2022-12-31 CHF77.14K
≈ $97.52K
CHF1.17 Billion
≈ $1.48 Billion
15142.076x +9097643.39%
2021-12-31 CHF7.44 Billion
≈ $9.40 Billion
CHF1.24 Billion
≈ $1.57 Billion
0.166x +10.25%
2020-12-31 CHF6.83 Billion
≈ $8.63 Billion
CHF1.03 Billion
≈ $1.30 Billion
0.151x --

About Sandoz Group AG

SW:SDZ Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$45.07 Billion
CHF35.65 Billion CHF
Market Cap Rank
#924 Global
#17 in Switzerland
Share Price
CHF82.38
Change (1 day)
-1.20%
52-Week Range
CHF52.88 - CHF83.38
All Time High
CHF83.38
About

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of ac… Read more